Have previously expressed concerns about Australian REE entities duplicating high cap ex on processing. HAS has found a commercially astute and elegant alternative.
China has considerable IP and is unlikely to be too concerned that LYC processes in Malaysia and, via Pentagon funding, soonish in USA, ASM in Korea, and IXR's Ugandan ionic clays soonish via Irish science in the UK.
CMX, ITM and ABx have REE bearing ionic clays so we may yet start mainland processing or 'overseas' in Tassie.
Perceiving Neo as a Trojan Horse just might be perceived as 'over extending the envelope'.
HAS Price at posting:
$4.94 Sentiment: Hold Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)